Lucid Diagnostics (LUCD) Return on Capital Employed (2021 - 2026)

Lucid Diagnostics has reported Return on Capital Employed for 6 years, with the latest figure at 149.92% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed fell 114178.0% year-over-year to 149.92%; the trailing twelve-month figure through Mar 2026 stood at 149.92% (down 114178.0% YoY), and the FY2025 full-year result was 174.08%, up 66805.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 149.92%, down from 66.79% in the prior quarter.
• The five-year high for Return on Capital Employed was 991.86% in Q1 2025, with the low at 5540.8% in Q4 2023.
• Historically, Return on Capital Employed has averaged 596.16% across 5 years, with a median of 260.61% in 2024.
• Annual changes were most pronounced in 2023 — Return on Capital Employed sank 533260 bps — and 2024, when it soared 407063 bps.
• Lucid Diagnostics' Return on Capital Employed stood at 208.2% in 2022, then slumped by 2561 bps to 5540.8% in 2023, then jumped by 73 bps to 1470.17% in 2024, then soared by 95 bps to 66.79% in 2025, then sank by 124 bps to 149.92% in 2026.
• The last three Return on Capital Employed figures came in at 149.92% (Q1 2026), 66.79% (Q4 2025), and 243.33% (Q3 2025), per Business Quant data.